An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes
- 23 December 2004
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 21 (4) , 347-352
Abstract
Objective The advantages of continuous subcutaneous insulin infusion (CSII) or insulin glargine have been demonstrated both in adult and paediatric diabetic patients; however, as no data comparing these two approaches during childhood are available, we have examined the efficacy of these two intensive approaches. Research Design and Methods We retrospectively evaluated data from 36 diabetic children, who had changed their previous insulin regimen [with isophane insulin (NPH) at bedtime] because of HbA1c levels >8.0%. Twenty patients underwent CSII, while the other 16 (significantly younger for age) started insulin glargine at bedtime. Results At 6 and 12 months, CSII‐treated patients showed a significant reduction in HbA1c values from 8.5 ± 1.8 to 7.4 ± 1.1% and to 7.6 ± 1.2%, respectively. The insulin requirement significantly decreased from 0.93 ± 0.2 IU/kg to 0.73 ± 0.2 IU/kg of body weight and to 0.74 ± 0.15 IU/kg of body weight, respectively, while no significant differences were observed for BMI SDS, fructosamine and severe hypoglycaemic events. The patients treated with glargine showed a small decline in HbA1c values from 8.9 ± 1.7 to 8.3 ± 0.9% (not significant) in the first 6 months of treatment and to 8.2 ± 0.9% after 12 months. Conclusion The basal insulin supplementation can be supplied effectively in children with type 1 diabetes by either CSII or insulin glargine. As previously reported for adults, it is confirmed that CSII is the best current intensive approach aimed to the improvement of glycaemic control. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- Beneficial Effects of Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Insulin Regimen Using Insulin Glargine in Type 1 DiabetesPediatrics, 2004
- A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections Using Insulin GlargineDiabetes Care, 2004
- Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin RegimensDiabetes Care, 2003
- An overview of insulin glargineDiabetes/Metabolism Research and Reviews, 2002
- The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic riskDiabetes/Metabolism Research and Reviews, 2002
- Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groupsPediatric Diabetes, 2002
- Comparative Trial Between Insulin Glargine and NPH Insulin in Children and Adolescents with Type I Diabetes MellitusJournal of Pediatric Endocrinology and Metabolism, 2002
- Physiological insulin replacement in type 1 diabetes mellitusExperimental and Clinical Endocrinology & Diabetes, 2001
- Intensified Insulin Therapy in the Type I Diabetic Adolescent: A Controlled TrialDiabetes Care, 1984
- Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.BMJ, 1978